Corbus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Clinical Updates

NEXT STORY
Zai Lab Announces Presentations at March Conferences
PREV STORY
Biocartis Group NV: Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ascendis Pharma A/S Announces Dosing of First Subjects in Phase 1 Trial of TransCon CNP

- TransCon CNP is Company’s Third Product Candidate in Clinic - COPENHAGEN, Denmark, May ...

author_avatar
NASDAQ Market News

Coherus Announces Proposed Public Offering of Common Stock

REDWOOD CITY, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

author_avatar
NASDAQ Market News

Amarin Reports First Quarter 2018 Financial Results and Provides Update on Operations

REDUCE-IT Study On-Track for Reporting Top-Line Results by the End of Q3 2018 Management ...

author_avatar
NASDAQ Market News